Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD80 anticorps

Cet anticorps Lapin Chimeric détecte spécifiquement CD80 dans ELISA et BR. Il présente une réactivité envers Humain.
N° du produit ABIN7072690

Aperçu rapide pour Recombinant CD80 anticorps (ABIN7072690)

Antigène

Voir toutes CD80 Anticorps
CD80

Type d'anticorp

Recombinant Antibody

Reactivité

  • 177
  • 120
  • 46
  • 8
  • 6
  • 6
  • 1
  • 1
  • 1
Humain

Hôte

  • 104
  • 96
  • 28
  • 21
  • 20
  • 2
  • 1
Lapin

Clonalité

  • 188
  • 82
  • 1
Chimeric

Conjugué

  • 105
  • 21
  • 20
  • 19
  • 14
  • 7
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD80 est non-conjugé

Application

  • 161
  • 96
  • 73
  • 41
  • 39
  • 26
  • 14
  • 13
  • 13
  • 13
  • 11
  • 10
  • 9
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Blocking Reagent (BR)

Clone

16C10
  • Fonction

    Anti-CD80 [16C10], Rabbit IgG, lambda

    Specificité

    This antibody binds human CD80 and inhibits the B7.1:CD28 pathway.

    Attributs du produit

    Original Species of Ab: Rhesus Macaque

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    This antibody was generated by immunization of cynomolgus monkeys with human B7.1 antigen.

    Isotype

    IgG lambda
  • Indications d'application

    This antibody can be used for identification of human B7.1 antigen and is capable of inhibiting the binding of B7.1 to CD28, however it does not block the binding of B7.1 to CTLA-4. This antibody further inhibits the production of IL-2. Blocking of the primary activation signal between CD28 and B7.1 (CD80) with these antibodies while allowing the unimpaired or coincident interaction of CTLA-4 and B7.1 represents a combined antagonistic effect on positive co-stimulation with an agonistic effect on negative signaling. The binding of the antibody to soluble B7.1 was tested using ELISA. This antibody tested positive for binding to human C1q protein. This antibody is reported to cause keratinocyte hyperproliferation and decrease in psoriasis by inhibiting the B7:CD28 pathway. This antibody is further reported to be useful for the treatment of intestinal inflammation and rheumatoid arthritis.

    Commentaires

    This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CD80

    Autre désignation

    CD80

    Sujet

    B7.1, CD28L, CD28LG, B7-1, B7, BB1, B7/BB1,T-lymphocyte activation antigen CD80, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1, CTLA4L, CTLA-4L

    UniProt

    P33681

    Pathways

    TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!